Risk of pancreatic cancer after eradication treatment of Helicobacter pylori
The elevated risk of developing pancreatic cancer among individuals with Helicobacter pylori infection seems to decrease after eradication treatment, reaching the risk estimates of the background population.
Authors
- Helgi Birgisson (ORCID: https://orcid.org/0000-0002-8246-6159)
- Giola Santoni (ORCID: https://orcid.org/0000-0002-9094-5037)
- Joonas H. Kauppila (ORCID: https://orcid.org/0000-0001-6740-3726)
- Jesper Lagergren (ORCID: https://orcid.org/0000-0002-5143-5448)
- My von Euler‐Chelpin (ORCID: https://orcid.org/0000-0003-2204-7048)
- Cecilia Radkiewicz (ORCID: https://orcid.org/0000-0003-0683-1537)
- Eivind Ness‐Jensen (ORCID: https://orcid.org/0000-0001-6005-0729)
- Shao-Hua Xie (ORCID: https://orcid.org/0000-0003-0864-8154)
- Anna-Klara Wiklund (ORCID: https://orcid.org/0000-0003-0974-3284)
Institutions
- University of Copenhagen (DK)
- Karolinska University Hospital (SE)
- Oulu University Hospital (FI)
- Levanger Hospital (NO)
- Karolinska Institutet (SE)
- Icelandic Cancer Society (IS)
Publication Details
- Journal
- European Journal of Cancer
- Published
- 2025-12-18
- DOI
- https://doi.org/10.1016/j.ejca.2025.116192
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00